Insurance
Latest News
April 25th 2025
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.
More News
A Push for Collaborative Care Calls ACO Models into Question
July 5th 2013In January 2012, 32 healthcare organizations became the first to participate in the Medicare Pioneer Accountable Care Organization (ACO) model. Now, over a year into the initiative, as many as 9 organizations are in deliberation of leaving the program.
Read More
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Read More
Medicare and Commercial Inpatient Resource Use: Impact of Hospital Competition
Hospitals in more competitive markets had significantly lower costs per discharge for both Medicare and privately insured patients.
Read More
